RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 NOACs
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28 suppl 2
SP 13
OP 15
DO 10.1177/1559897715612452
UL http://mdc.sagepub.com/content/15/28_suppl_2/13.abstract
AB There are now 4 novel oral anticoagulants available as an alternative to vitamin K antagonists for the risk reduction of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. However, many unanswered questions remain about their use in clinical practice, and numerous trials are ongoing.